Delivery Order SPE2DB22D1202-SPE2DB25FVLJ5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $35,155.89 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of PREVNAR 20 syringe units (0.5ML). This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open market solicitation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is scheduled for...
- The Defense Logistics Agency awarded a $40,118.88 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringe supply (0.5mL) under a firm fixed-price contract. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,052.93 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on June 2, 2025, with completion scheduled for June 3, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,782.77 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) under a firm fixed-price contract type. The award was made on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a non-set-aside competitive award, with performance to be completed at the vendor's Conshohocken, Pennsylvania location. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $6,337.95 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5 mL syringe format. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,703.93 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 Syringe 0.5ML, a pneumococcal vaccine product. The contract is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and was awarded on August 8, 2025, with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $47,295.80 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) with a completion date of September 10, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location in the same city....
- The Defense Logistics Agency awarded a $36,998.71 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5mL syringes. This non-competitive delivery order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a routine pharmaceutical procurement fulfilling ongoing federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor within the...
- The Defense Logistics Agency awarded a delivery order valued at $8,168.85 to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine syringes (0.5ML) on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The vaccine will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $86,365.07 delivery order to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) under a firm fixed-price contract type. The award, announced on July 16, 2025, with an ultimate completion date of July 17, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this medical supply delivery order, which will be performed at the...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVLJ5Delivery Order
The Defense Logistics Agency awarded a $35,595.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5ML) on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-set-aside contract represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The prime contractor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. This delivery order supports the Defense Health Agency and broader military healthcare programs by supplying PREVNAR 20 pneumococcal vaccine in syringe format. AmerisourceBergen's comprehensive IDC vehicle enables flexible pharmaceutical procurement across multiple therapeutic domains, including vaccines, specialty medications, and medical supplies on a global basis. The company maintains significant capacity through competitive federal contracting, as evidenced by its extensive portfolio of vaccine and pharmaceutical deliveries to DLA and related federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.6k | 9/15/25 |